

Cellares Corporation, a life sciences technology company, has secured $82 million in Series B funding. Decheng Capital and Eclipse Ventures led the round.
Source: Press Release
Cellares Corporation, a life sciences technology company, has secured $82 million in Series B funding.
Cellares Corporation, a life sciences technology company, has secured $82 million in Series B funding. Decheng Capital and Eclipse Ventures led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination